Jackson Square Capital, LLC Dexcom Inc Transaction History

Jackson Square Capital, LLC

$383 Million
Q4 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$86.06 - $137.93 $2.8 Million - $4.5 Million	-32,593 Reduced 85.03%	5,737 $535,000
Q2 2023 Jul 28, 2023	BUY	$112.47 - $130.98 $302,094 - $351,812	2,686 Added 7.54%	38,330 $4.93 Million
Q1 2023 Apr 21, 2023	SELL	$104.0 - $122.92 $178,360 - $210,807	-1,715 Reduced 4.59%	35,644 $4.14 Million
Q4 2022 Jan 23, 2023	BUY	$84.98 - $122.67 $415,382 - $599,610	4,888 Added 15.05%	37,359 $0
Q3 2022 Oct 13, 2022	SELL	$76.35 - $94.18 $15,957 - $19,683	-209 Reduced 0.64%	32,471 $2.62 Million
Q2 2022 Jul 25, 2022	BUY	$67.99 - $132.89 $1.89 Million - $3.7 Million	27,859 Added 577.87%	32,680 $2.44 Million
Q1 2022 Apr 20, 2022	BUY	$94.08 - $130.2 $53,061 - $73,432	564 Added 13.25%	4,821 $2.47 Million
Q4 2021 Jan 19, 2022	BUY	$129.87 - $162.82 $8,311 - $10,420	64 Added 1.53%	4,257 $2.29 Million
Q3 2021 Oct 21, 2021	BUY	$106.71 - $143.18 $106 - $143	1 Added 0.02%	4,193 $2.29 Million
Q2 2021 Jul 20, 2021	SELL	$80.99 - $107.93 $173,075 - $230,646	-2,137 Reduced 33.77%	4,192 $1.79 Million
Q1 2021 May 18, 2021	SELL	$84.79 - $104.74 $31,117 - $38,439	-367 Reduced 5.48%	6,329 $2.28 Million
Q4 2020 Mar 05, 2021	SELL	$78.0 - $104.5 $108,888 - $145,882	-1,396 Reduced 17.25%	6,696 $2.48 Million
Q3 2020 Nov 17, 2020	SELL	$95.51 - $112.95 $75,166 - $88,891	-787 Reduced 8.86%	8,092 $3.34 Million
Q2 2020 Aug 18, 2020	BUY	$62.68 - $105.34 $81,107 - $136,309	1,294 Added 17.06%	8,879 $3.6 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $86,452 - $136,814	1,809 Added 31.32%	7,585 $2.04 Million
Q4 2019 May 15, 2020	BUY	$36.62 - $57.29 $211,517 - $330,907	5,776 New	5,776 $1.26 Million

Others Institutions Holding DXCM

# of Institutions

1,084

Shares Held

352M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.2B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Capital, LLC with notifications on news.

Account